baber/WOPTO huggingface dataset:
Patent CA-2585391-A1 (CA)
Inventor: BARNICKI SCOTT DONALD
IPC: C10J3/00
Filed: 2005-10-18
Abstract: A process for satisfying variable power demand and a method for maximizing the monetary value of a synthesis gas stream are disclosed. One or more synthesis gas streams (18; 20; 26) are produced by gasification of carbonaceous materials and passed to a power producing zone (38) to produce electrical power during a period of peak power demand or to a chemical producing zone (54) to produce chemicals such as, for example, methanol, during a period of off-peak power demand. The power-producing zone (38) and the chemical-production zone (54) which are operated cyclically and substantially out of phase in which one or more of the combustion turbines are shut down during a period of off-peak power demand and the syngas fuel diverted to the chemical producing zone. This out of phase cyclical operational mode allows for the power producing zone (38) to maximize electricity output with the high thermodynamic efficiency and for the chemical producing zone (54) to maximize chemical production with the high stoichiometric efficiency. The economic potential of the combined power and chemical producing zones is enhanced.
Patent CA-2585907-A1 (CA)
Inventor: POMPEJUS MARKUS
IPC: C12N1/21
Filed: 2000-06-23
Abstract: Isolated nucleic acid molecules, designated HA nucleic acid molecules, which encode novel HA proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing HA  nucleic acid molecules, and host cells into which the expression vectors have been introduced.  The invention still further provides isolated HA proteins, mutated HA  proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of HA genes in this organism.
Patent CA-2586221-A1 (CA)
Inventor: NADLER DONALD
IPC: E21B10/44
Filed: 2004-11-12
Abstract: A system, apparatuses and methods for anchoring are provided. The system includes two-stage drill bit and a method of anchoring into a two-stage hole drilled by the drill bit. The apparatus of the instant invention includes a two-stage drill bit for drilling a pilot hole for a common nail into a material such as concrete, stone, masonry or cementuous or other materials.  The method of the instant invention includes the steps of drilling a first hole within a material to which an object is to be anchored, drilling a second hole concentric with the first hole, and placing an anchor within the holes.
Patent CA-2589333-A1 (CA)
Title: Wireless metropolitan area network architecture for managing network resources and mobility
Inventor: ZAKI MAGED M
IPC: H04W84/04
Filed: 2005-10-31
Abstract: The present invention proposes an infrastructure to enable seamless mobility for wireless metropolitan area networks (WMANs) and to provide for management of spectrum and network resources. An WMAN reference model is introduced where the radio resource management (RRM) and handover (HO) sub~layer is introduced into the protocol stack. The WMAN management plane is responsible for the RRM  and HO management. Several physical and logical network architecture options for WMAN management are proposed.
Patent CA-2589459-A1 (CA)
Title: Method of measuring cholesterol in remnant-like lipoproteins
Inventor: NAKANO TAKAMITU
IPC: G01N33/48
Filed: 2005-11-28
Abstract: There are provided a method and reagent for measuring cholesterol in remnant-like lipoprotein in a sample with high sensitivity by more simple operation. The method for measuring cholesterol in remnant-like lipoprotein uses a cholesterol esterase, in which the activity ratio of a lipoprotein lipase to a cholesterol esterase (lipoprotein lipase activity/cholesterol esterase activity) is from 12 to 7000 in a method for measuring cholesterol in the lipoprotein by measuring hydrogen peroxide or a reduced coenzyme obtained by allowing the cholesterol esterase and a cholesterol oxidase or a cholesterol dehydrogenase to act on a test sample containing a lipoprotein.
Patent CA-2590151-A1 (CA)
Inventor: PRENCIPE MICHAEL
IPC: A61K8/24
Filed: 2005-11-10
Abstract: A stable and efficacious antiplaque, anticalculus, and antigingivitis oral composition is provided having an antibacterial ingredient comprising one or more active compounds found in an extract of magnolia combined with an anticalculus system comprising tetrasodium pyrophosphate (TSPP) about 1 to about 2.5% and sodium tripolyphosphate (STPP) about 1 to about 10%. The oral composition can be in the form of a mouth rinse or dentifrice, including toothpaste, gels, powders, as well as confectionaries, lozenges, and the like.  Methods of making and using the oral composition are also provided.
Patent CA-2590300-A1 (CA)
Title: System and process for concentrating hydrocarbons in a bitumen feed
Inventor: NOBLE IAN MACKAY
IPC: C10G1/04
Filed: 2007-05-29
Abstract: A system and process for concentrating hydrocarbon in a bitumen feed comprising bitumen, water and solids. The system comprises an inclined plate separator, a hydrocarbon cyclone and a centrifuge. The inclined plate separator separates the bitumen feed into a first overflow stream and a first underflow stream, the first overflow stream having a first bitumen concentration greater than that of the first underflow stream. The hydrocarbon cyclone separates the first underflow stream into a second overflow stream and a second underflow stream. The centrifuge separates the second overflow stream into a third overflow stream and a third underflow stream, the third overflow stream having a third bitumen concentration that is greater than that of the third underflow stream.
Patent CA-2590962-A1 (CA)
Inventor: LAQUERRE SYLVIE
IPC: C07D265/30
Filed: 2005-12-06
Abstract: Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i e., including but not limited to Arenaviridae (Junin, Machupo, Guanavito, Sabia and Lassa), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever).
Patent CA-2591434-A1 (CA)
Title: Transistor matrix switched reluctance variable speed motor drive
Inventor: CADDELL RICHARD
IPC: H02P25/08
Filed: 2006-01-09
Abstract: A multi-phase motor drive includes coil magnets that generate a magnetic field when energized with an electrical current. The coil magnets are configured in an electrical matrix. Switches are arranged in an electrical circuit with the coil magnets. Each coil magnet is in electrical communication with at least two of the switches and each switch is in electrical communication with more than one coil magnet. The switches operate in pairs to energize the coil magnets and the multi-phase motor drive includes a lesser number of switch pairs than coil magnets.
Patent CA-2593059-A1 (CA)
Title: Monoaxially oriented polypropylene film with high transverse tear propagation resistance
Inventor: MUESSIG BERNHARD
IPC: B29C48/08
Filed: 2007-06-29
Abstract: Backing film which comprises at least one polypropylene and has been longitudinally monoaxially oriented, characterized in that at least one nucleating agent has been inhomogeneously distributed in the backing film.
Patent CA-2594040-A1 (CA)
Title: Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
Inventor: HUNG CHIEN-FU
IPC: A61K48/00
Filed: 2005-12-30
Abstract: An immunotherapeutic strategy is disclosed that combines antigen-encoding DNA  vaccine compositions combined with siRNA directed to pro-apoptotic genes, primarily Bak and Bax, the products of which are known to lead to apoptotic death. Gene gun delivery (particle bombardment) of siRNA specific for Bak and/or Bax to antigen-expressing DCs prolongs the lives of such DCs and lead to enhanced generation of antigen-specific CD8+T cell-mediated immune responses in vivo. Similarly, antigen-loaded DC~s transfected with siRNA  targeting Bak and/or Bax serve as improved immunogens and tumor immunotherapeutic agents.
Patent CA-2594400-A1 (CA)
Inventor: JOHANSSON HELENA
IPC: A61B19/00
Filed: 2006-01-09
Abstract: The present invention relates to a draping product with an adhesive edge, incision film or tape, provided with a soft, skin friendly adhesive. In accordance with invention, the draping product, the incision film or the tape is leakproof in accordance with the MHC Leakage Test with a groove depth of 50 micrometres.
Patent CA-2595214-A1 (CA)
Inventor: TORMOS GREGORY V
IPC: A61Q5/00
Filed: 2006-01-25
Abstract: The present invention relates to a composition comprising an effective amount of diiodomethyl-p-tolylsulfone wherein the diiodomethyl-p-tolylsulfone is present as a particulate dispersion, an effective amount of a surfactant, and an effective amount of an antidandruff active.
Patent CA-2595863-A1 (CA)
Inventor: YAMADA YUKIO
IPC: B05B5/025
Filed: 2006-05-31
Abstract: A sprayer (1) having an air motor (2) and a rotary atomizer head (3) is installed on the front side of a housing (9), and a high-voltage generator (7) for applying a high-voltage to a coating material via the air motor (2) etc.  is installed on the rear side of the housing (9). An outer surface (9A) of the housing (9) is covered by a cover (10). Axially both ends of the cover (10) are fixed to axially both ends of the housing (9) respectively, forming an annular space (12) between the cover (10) and the housing (9). The outer surface of the cover (10) is electrically charged with a high-voltage, and the annular space (12) can reduce leakage of the electric charges via the housing (9).
Patent CA-2598410-A1 (CA)
Title: Forme pharmaceutique orale de losartan
Inventor: CASTAN CATHERINE
IPC: A61K9/54
Filed: 2006-02-21
Abstract: Le domaine de la présente invention est celui des formes pharmaceutiques orales de losartan, ainsi que des traitements et méthodes d'administration y afférentes. L'invention concerne l'utilisation, dans une forme pharmaceutique orale comprenant du losartan, d'un enrobage ou d'une matrice incluant ledit losartan et permettant la libération contrôlée dudit losartan, pour faire en sorte que cette forme administrée oralement à un échantillon de sujets conduise, quel que soit l'état nourri ou à jeun des sujets, à la diminution de l'écart type interindividuel du Cmax, ce qui permet d'assurer une plus faible variabilité de l'efficacité et de la sécurité thérapeutique de la forme pharmaceutique, par rapport à une forme pharmaceutique à libération immédiate de losartan administrée à ce même échantillon de sujets, à une même dose. Un autre but de l'invention est de fournir une forme pharmaceutique orale de losartan administrable une fois par jour, au moins aussi efficace que les formes "une prise par jour" et que les formes "deux prises par jour". L'invention est donc une forme pharmaceutique orale à libération modifiée de losartan comprenant une pluralité de micro-unités de losartan (diamètre moyen: 50-1000 µm) permettant d'obtenir, après une prise, un profil plasmatique du type de ceux montrés dans la figure 10.
Patent CA-2600548-A1 (CA)
Title: System for automatically inflating temperature regulated blankets and a blanket for coupling to the system
Inventor: FREY WILLIAM E
IPC: A61F7/00
Filed: 2006-02-16
Abstract: A convective warmer to which blankets of different dimensions may be connected is capable of providing air to the various blankets at flow rates that optimally inflate those blankets to achieve the optimal clinical result for the patients covered by those blankets. The blanket connected to the warmer may range from a full size adult warming blanket to a pediatric or neonate warming blanket. There is provided on each blanket a code, marking or marker, to be read by a sensor(s) provided at the outlet of the warmer, that identifies the type of blanket when the blanket is coupled to the warmer.  Consequently, heated air may be automatically output by the warmer to the blanket at the appropriate flow rate of that blanket to optimally inflate the blanket without any need for intervention by a user. In addition to being used to control the flow rate of the heated air, the code from the blanket may also be used to control the temperature of the heated air to be input to the blanket.
Patent CA-2602386-A1 (CA)
Title: Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
Inventor: MEEHAN ALAN
IPC: A61K31/435
Filed: 2006-03-21
Abstract: A method of treating Alzheimer~s disease, Parkinson~s disease, sexual dysfunction or erectile dysfunction in a man by administration of a 5alpha reductase inhibitor together with a testosterone supplement is described. The method is also concerned with the use of the 5alpha reductase inhibiting compound and the testosterone supplement together with another agent useful for treating erectile dysfunction, including PDE V inhibitors; AGE (advanced glycation end-product) breakers; alpha 1 blockers; alpha 1A antagonists; alpha 2 antagonists; dopamine agonists; dopamine D4 agonists; melanocortin agonists;  oxytocin agonists; prostaglandin; radical scavengers; rotamase inhibitors;  aviptadil; nitroglycerine; and GPCR agonists for treating male sexual dysfunction or erectile dysfunction.
Patent CA-2603145-A1 (CA)
Title: Process for preparing cinacalcet hydrochloride
Inventor: WIZEL SHLOMIT
IPC: C07C209/22
Filed: 2006-05-16
Abstract: Processes for preparing cinacalcet are provided.
Patent CA-2603226-A1 (CA)
Inventor: CHEN ZHI-YING
IPC: A23L27/30
Filed: 2007-09-18
Abstract: It has been well established that tea elements have broad health benefits, including anti--cancer, -atherosclerosis, -obesity, and -diabetes, and neuron-protection effects, etc.    VitaSugar® IMO is a non-digestible health sweetener with a series of additional health benefits, e.g., prevention of colon cancer, constipation, and dental cavity, and promotion of favorable bacterial flora in human colon as prebiotic function, etc. A  beverage comprises of these two elements will provide consumers a class of tasteful drinks with superior health benefits.
Patent CA-2604135-A1 (CA)
Inventor: BEDOYA FELIPE
IPC: C07K16/18
Filed: 2006-04-07
Abstract: This invention provides a novel pyrin-only protein (POP2), polypeptides, nucleic acids encoding them and methods for making and using them. The polypeptides of this invention have nuclear factor -.kappa.B (NF-.kappa.B) modulating activity. NF-.kappa.B is pivotal for transactivation of cell-cycle regulatory, cytokine and adhesion molecule genes and is dysregulated in many cancers, neurodegenerative disorders, and inflammatory diseases. Proteins with Pyrin and/or caspase recruitment (CARD) domains have roles in apoptosis, innate immunity, and inflammation. Many pyrin domain proteins modulate NF-.kappa.B activity as well as participate in assembling both the perinuclear "apoptotic speck" and the pro- IL1.beta./IL-18 converting inflammasome complex. 'Pyrin-only' proteins are attractive as negative regulators of pyrin domain-mediated functions and one such protein, POP1 , has been reported. We teach a second Pyrin-only protein (POP2). POP2 is a 294 nt single exon gene located on human chromosome (3) encoding a (97) amino acid protein with sequence and predicted structural similarity to other pyrin domains. Highly similar to pyrin domains in CATERPILLER (CLR, NLR, NALP) family proteins, POP2 is less like the prototypic Pyrin and ASC pyrin domains. POP2 is expressed principally in peripheral blood leukocytes and displays both cytoplasmic and nuclear expression patterns in transfected cells. TNF.alpha.-stimulated and p65 (ReIA) induced NF-.kappa.B-dependent gene transcription is inhibited by POP2 in vitro by a mechanism involving changes in NF-.kappa.B nuclear import or distribution. While colocalizing with ASC in perinuclear specks, POP2 also inhibits the formation of specks by the CLR protein CIAS1/NALP3. Together these observations indicate that POP2 is a negative regulator of NF-.kappa.B  activity that may influence the assembly of pyrin-domain dependent complexes.
Patent CA-2605517-A1 (CA)
Title: Moisture-curable composition featuring increased elasticity
Inventor: BURCKHARDT URS
IPC: C08G18/10
Filed: 2006-04-28
Abstract: The invention relates to moisture-curable compositions that are provided with increased elasticity while having good mechanical properties and adhesion.  Said compositions contain at least on silane-functional polymer A, at least one aminosilane AS2, and at least one .alpha.-functional organodialkoxysilane at an amount of 0.6 to 5.0 parts by weight relative to 100 parts by weight of polymer A. Also disclosed are the production and use of the inventive compositions, especially as a sealant and adhesive.
Patent CA-2606927-A1 (CA)
Title: Curved blade for wind turbines
Inventor: VETTESE SHAROLYN
IPC: F04D29/38
Filed: 2007-10-18
Abstract: A curved blade for use on horizontal wind turbines, the blade comprising a substantially semicircular tip portion, a substantially semicircular counter-tip portion opposite the tip portion, and a body portion extending between the tip portion and the counter-tip portion, the body portion being further defined by a concave curved trailing edge and a convex curved leading edge.
Patent CA-2606948-A1 (CA)
Title: Nageoire de plateforme de soufflante
Inventor: AUBIN STEPHAN
IPC: F01D9/00
Filed: 2007-10-18
Abstract: L'invention concerne une plateforme de soufflante d'une turbomachine double flux avec un flux primaire et un flux secondaire. La plateforme définit une partie de la surface du nez autour duquel circule le flux primaire et qui porte des aubes s'étendant radialement extérieurement à partir de cette plateforme. La plateforme comporte entre deux aubes adjacentes au moins une nervure dépassant dans l'espace entre les deux aubes, cette nervure étant destinée à participer à la compression de l'air du flux primaire.
Patent CA-2610020-A1 (CA)
Title: Rf utilization calculation and reporting method for 802.11 wireless local area networks
Inventor: MOWER CARL
IPC: H04L12/28
Filed: 2006-04-12
Abstract: METHOD FOR REPORTING RAFIO FREQUENCY UTILIZATION ABSTRACT OF THE INVENTION A  radio frequency exchange utilization calculation method in wireless medium that comprises identifying a plurality of packet counters pertaining to each of a plurality of transmission speeds and to each of a plurality of components of the wireless medium, identifying a plurality of octet counters pertaining to each of a plurality of transmission speeds and to each of a plurality of components of the wireless medium, incrementing each packet counter by one in accordance to the speed a data packet is transmitted, incrementing each plurality of octet counters by a number of octets in the data packet, calculating a packet weighted effective bit rate, calculating an octet weighted effective bit rate, calculating a total data exchanged, and calculating a percentage for the radio frequency exchange performance.
Patent CA-2614553-A1 (CA)
Inventor: CHAKRAPANI SRINIVASAN
IPC: C09K23/54
Filed: 2006-06-21
Abstract: An emulsifier for use in forming a film for a suspended particle device (SPD) wherein the film is comprised of a cross-linked matrix polymer having a plurality of droplets of a liquid light valve suspension distributed therein. The emulsifier is formed of a copolymer material comprising at least first and second segments, the segments differing from one another in at least one of their chemical affinities, their compositions and their polarities. A first one of the segments is soluble in an uncured liquid matrix polymer used in forming the film, but insoluble in a liquid suspension medium of which the droplets are dispersed. A second segment is soluble in the liquid suspending medium in the droplets and insoluble in the uncured liquid matrix polymer. The first and second segments have substantially the same index of refraction and the index of refraction of the segments is within 0.010 of that of each phase of an emulsion formed with the emulsifier. In one embodiment, the first segment is comprised of a material selected from the group consisting of linear organosiloxanes, branched organosiloxanes, linear alkyl groups, branched alkyl groups, linear fluoroalkyl groups and branched fluoroalkyl groups. The second segment, in turn, is comprised of a material selected from the group consistingof linear esters, branched esters, linear (meth)acrylate, branched (meth)acrylate, linear amide, branched amide, linear amine, branched amine, linear epoxy groups, branched epoxy groups, linear groups comprising hydroxyl or acid groups and branched groups comprising hydroxyl or acid groups. The emulsifier is adapted to substantially prevent coalescence of the droplets of the liquid light valve suspension during formation of the film by retarding the growth of the droplets.
Patent CA-2616426-A1 (CA)
Inventor: MAYR DOROTHEA
IPC: A61K33/24
Filed: 2008-01-25
Abstract: The present invention is directed to a composition comprising a vanadium--containing phosphatase inhibitor and a polyol. In the presence of the polyol the effect of the inhibitor is enhanced, even in the presence of chelating agents or reducing agents. The invention also concerns the use of the inventive composition for inhibiting a phosphatase, as well as kits comprising the composition.
Patent CA-2617328-A1 (CA)
Title: Dual channel downhole telemetry
Inventor: DUDLEY JAMES H
IPC: E21B47/12
Filed: 2003-02-13
Abstract: The present disclosure provides several methods for selecting and transmitting information from downhole using more than one channel of communication wherein data streams transmitted up each communications channel are each independently interpretable without reference to data provided up the other of the communications channels. Preferred embodiments incorporate the use of a combination of at least two of mud-based telemetry, tubular-based telemetry, and electromagnetic telemetry to achieve improved results and take advantage of opportunities presented by the differences between the different channels of communication.
Patent CA-2622385-A1 (CA)
Inventor: MEZEI ALEXANDRU V
IPC: C22B3/04
Filed: 2008-02-19
Abstract: By the process of the present invention the cyanide leaching of precious and platinum group metals is improved by using sodium hydroxide to dissolve the mineral matrix that encapsulates the pay metals and their respective containing minerals allowing for the penetration of the leaching reagent whilst dispersing the fine materials hence enhancing the rate and extent of dissolution of the said pay metals and their transfer into the aqueous phase. A process wherein the sodium hydroxide is produced on site through an alkalinity exchange process comprised of carbonation using carbon dioxide followed by liming-caustification of the carbonated slurry using calcium hydroxide. The resulting limed-caustic slurry is subjected to solid-liquid separation and subsequent washing producing a solution containing sodium hydroxide. Sodium cyanide is added to the aforementioned sodium hydroxide solution which therefore becomes fresh lixiviant that is directed to the leaching of the pay metals contained in the orebody.
Patent CA-2625763-A1 (CA)
Title: Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
Inventor: PROFETA ROBERTO
IPC: A61K31/435
Filed: 2006-10-06
Abstract: The invention relates to quaternary .alpha.-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.